Technique to process xenogenic tissues for cardiovascular implantation - A preliminary report

Current Science

Volumn 91, Issue 8, 2006, Pages 1068-1073

  Guhathakurta, S ^a,b   Varghese, S ^b   Balasubramanian, V ^a   Agarwal, R ^b   Murthy, B S ^b   Veerappan, S ^b   Padmaja, P ^b   Cherian, K M ^b  

^a INDIAN INSTITUTE OF TECHNOLOGY MADRAS   (India)

^b Frontier Life Line Pvt   (India)

Author keywords

Anti calcium treatment; Calcific degeneration; Decellularization; Xenograft

Indexed keywords

ANIMALIA; BOS TAURUS; SUIDAE;

EID: 33750974478     PISSN: 00113891     EISSN: 00113891     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Cary, W. A., Mortimer, J. K. B., Willard, M. D., Hilgenberg, D., Gus, J. V., David, F. T. and Joren, C. M., Risk of reoperative valve replacement for failed mitral and aortic bioprostheses. Ann. Thorac. Surg., 1998, 65, 1545-1552.
2. Frederick, J. S. and Robert, J. L., Calcification of tissue heart valve substitutes: Progress toward understanding and prevention. Ann. Thorac. Surg., 2005, 79, 1072-1080.
3. 3 preincubations. J. Biomed. Mater. Res., 1991, 25, 905-935.
4. Okoshi, T., Noishiki, Y. and Tomizawa, Y., A new bioprosthetic cardiac valve with reduced calcification. ASAIO Trans., 1990, 36, M411-M414.
5. Ichikawa, Y., Noishiki, Y. and Soma, T., A new antithrombogenic RV-PA valved conduit. ASAIO J., 1994, 40, M714-M718.
6. Elkins, R. C., Dawson, P. E., Goldstein, S., Walsh, S. P. and Black, K. S., Decellularised human valve allografts. Ann. Thorac. Surg. (Suppl.), 2001, 71, S428-S532.
7. Christine, E. S. and Jennie, M. B., Acellular tissues: natural biomaterials for tissue repair and tissue engineering. Biomaterials, 2000, 21, 2215-2231.
8. Courtman, D. W., Pereira, C. A., Kashef, V., McComb, D., Lee, J. M. and Wilson, G. J., Development of a pericardial acellular matrix biomaterial: biochemical and mechanical effects of cell extraction. J. Biomed. Mater. Res., 1994, 28, 655-666.
9. Rygg, I. H., Ladefoged, J., Jorgensen, K. and Elling, F., Prevention of protein insulation and the related deterioration of bioprosthetic materials by incorporation of heparin-protein complex: biologic and bioprosthetic valves. In Proceedings of the Third International Symposium (eds Bodner, E. and, Yacoub, M.), York Medical Books.
10. Malone, J. M., Brendel, K., Duhamel, R. C. and Reivert, R. L., Detergent extracted small-diameter vascular prosthesis. J. Vasc. Surg., 1984, 1, 181-191.
11. Lalka, S. G., Oelker, L. M. and Malone, J. M., Acellular vascular matrix: a natural endothelial cell substrate. Ann. Vasc. Surg., 1989, 3, 108-117.
12. Wilson, G. J., Yeger, H., Klement, P., Lee, J. M. and Courtman, D. W., Acellular matrix allograft small caliber vascular prostheses. ASAIO Trans., 1990, 36, M340-M343.
13. Courtman, D. W. and Wilson, G. J., Development of an acellular matrix vascular xenograft: Modification of the in vivo immune response in rats. In Proceedings of the Society for Biomaterials, 25th Annual Meeting, 1999, p. 20.
14. Erwin, R., Marie, T. K., Gerd, S., Gernot, S., Ernst, W., Paul, S. and Guenter, W., Decellularization protocols of porcine heart valves differ importantly in efficiency of cell removal and susceptibility of the matrix to recellularization with human vascular cells. J. Thorac. Cardiovasc. Surg., 2004, 127, 399-405.
15. Augustinus, B., Tobias, S., Omhe, E. T., Gudrun, B., Tanja, H., Gustav, S. and Axel, H., Tissue engineering of heart valves - human endothelial cell seeding of detergent acellularized porcine valves. Eur. J. Cardio-thorac. Surg., 1998, 14, 279-284.
16. Hawkins, J. A. et al., Immunogenicity of decellularized cryopreserved allografts in paediatric cardiac surgery: comparison with standard cryo-preserved allografts. J. Thorac. Cardiovasc. Surg., 2003, 126, 247-253.
17. Christine, E. S. and Jennie, M. B., Acellular vascular tissues: natural biomaterials for tissue repair and tissue engineering. Biomaterials, 2000, 21, 2115-2231.
18. Yukio, I., Yasuharu, N. and Takayuki, K., Use of a bovine jugular vein graft with natural valve for RVOT reconstruction: A one year animal study. J. Thorac. Cardiovasc. Surg., 1997, 114, 224-233.
19. Pascal, M. D., Shigeyuki, O., Jessa, Y., Willem, F. and Wolfgang, K., Lack of calcification of tissue engineered heart valves in juvenile sheep. Sem. Thorac. Cardiovas. Surg., 2001, 13, 93-98.
20. Colomb, G., Schoen, F. J., Smith, M. S., Linden, J., Dixon, M. and Levy, R. J., The role of glutaraldehyde-induced cross-links in calcification of bovine pericardium used in cardiac valve bioprostheses. Am. J. Pathol., 1987, 127, 122-130.
21. Peter, Z., Deon, B. and Paul, H., Carbodimide treatment dramatically potentiates the anticalcific effect of alpha amino oleic acid on glutaraldehyde-fixed aortic wall tissue. Ann. Thorac. Surg., 2005, 79, 905-910.
22. Tetsya, K., Yutaka, M. and Takashi, T., Cellular biology of cryopreserved allograft valves. J. Med. Invest., 2001, 48, 123-132.
23. Welters, M. J. et al., A broad and strong humoral immune response to donor HLA after implantation of cryopreserved human heart valve allografts. Hum. Immunol., 2002, 63, 1019-1025.
24. Elkins, R. C., Lane, M. M., Capps, S. B., McCue, C. and Dawson, P. E., Humoral immune response to allograft valve tissue pretreated with an antigen reduction process. Sem. Thorac. Cardiovasc. Surg. (Suppl. 1), 2001, 13, 82-86.
25. Francisco, D. A. et al., Immunological and echocardiographic evaluation of decellularized versus cryo-preserved allografts during the Ross operation. Eur. J. Cardiothorac. Surg., 2005, 27, 572-578.
26. Narendra, V., Danielle, H., Eyal, L., Jonathan, Z. B. and Robert, J. L., Prevention of bioprosthetic heart valve calcification by ethanol preincubation. Efficacy and mechanisms. Circulation, 1997, 95, 479-488.
27. Jocelyn, N. C., Mathew, F. O., Paul, A., Rochard, W. B. and Robert, J. L., Prevention of calcification of bioprosthetic heart valve cusp & aortic wall with ethanol and aluminium chloride. Ann. Thorac. Surg., 2005, 79, 897-904.
28. Jason, H. and Michael, H., Virus safety of a porcine-derived medical device: Evaluation of a viral inactivation method. Biotechnol. Bioeng., 2002, 79, 211-216.